← Leaderboards
Woo Young Lee
The Trustees Of The Stevens Institute Of Technology
$1,498,170
Attributed
$2,648,656
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $711.6K · FY2013–19$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,648,656 · 3
By mechanism
R33$1,615,293 · 1
R21$1,033,363 · 2
Top collaborators
- Jenny Zilberberg9 shared
- Benjamin Tycko1 shared
Most similar at The Trustees Of The Stevens Institute Of Technology
Same institution · by research overlap
- Xiaojun Yu$1,359,846
- Hongjun Wang$1,756,094
Others in their field
Top investigators on “Bone”
- David Heimbrook · Leidos Biomedical Research, Inc.$240,577,094
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Richard A Gibbs · Baylor College Of Medicine$64,141,825
- Jeffrey Krischer · University Of South Florida$61,545,982
Research focus
BoneAntibodiesPharmaceutical PreparationsOsteoblastsIn VitroPerfusionResistanceNeoplasm MetastasisSerumMalignant - DescriptorBone MarrowPlasma CellsMultiple MyelomaNovel TherapeuticsBone DevelopmentNeoplastic CellDrug ResistanceCellsEvaluationMalignant Neoplasm Of ProstateLesionB Lymphoid MalignancyRelapseImplant
Grant awards (12)
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$374,560
R33 · FY2019 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$218,834
R33 · FY2019 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$118,189
R33 · FY2019 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$389,121
R33 · FY2018 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$121,845
R33 · FY2018 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$29,161
R33 · FY2018 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells$363,583
R33 · FY2017 · CA
Microfluidic approach for the development of a three-dimensional bone marrow micr$133,331
R21 · FY2016 · CA
Microfluidic approach for the development of a three-dimensional bone marrow micr$266,662
R21 · FY2015 · CA
Microfluidic approach for the development of a three-dimensional bone marrow micr$285,687
R21 · FY2014 · CA
Microfluidic 3D Culture of Primary Osteocytes$153,487
R21 · FY2014 · AR · contact PI
Microfluidic 3D Culture of Primary Osteocytes$194,196
R21 · FY2013 · AR · contact PI